The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

The point-of-care (POC) HbA1c testing market has been expanding swiftly in recent years and is set for continued growth. With increasing diabetes prevalence and technological advancements, the market is poised to grow from $0.85 billion in 2023 to $0.95 billion in 2024 at a compound annual growth rate (CAGR) of 12.0%.

Drivers of Historic Growth

Strong Economic Growth in Emerging Markets

• Emerging markets have seen robust economic development, facilitating increased healthcare spending and access to POC testing technologies.

Rising Diabetes Prevalence

• The global surge in diabetes cases, fueled by lifestyle changes and aging populations, has significantly driven the demand for HbA1c testing.

Impact of COVID-19

• The COVID-19 pandemic has heightened awareness and demand for accessible and rapid diagnostic testing, including for chronic conditions like diabetes.

Increased Disposable Income

• Higher disposable incomes have enabled more individuals to afford regular health check-ups, including POC HbA1c tests.

View More On The Poc Hba1C Testing Market Report 2024 – https://www.thebusinessresearchcompany.com/report/poc-hba1c-testing-global-market-report

Future Market Projections

The POC HbA1c testing market is expected to continue its rapid growth, reaching $1.46 billion by 2028, with a CAGR of 11.4%. Several factors will drive this growth during the forecast period.

Rising Government Support

• Government initiatives and funding for diabetes management and prevention are expected to boost the market.

Increasing Prevalence of Type II Diabetes

• The growing number of type II diabetes cases will continue to fuel demand for HbA1c testing.

Easy Accessibility and Faster Results

• POC tests offer quicker results compared to conventional laboratory testing, making them highly attractive for immediate diagnosis and management.

Technological Advances

• Innovations in testing technologies, including microfluidic immunofluorescence and capillary electrophoresis, are transforming the market.

Key Trends in the Forecast Period

Focus on HbA1c Microfluidic Immunofluorescence Tests

• This technology offers precise and rapid results, enhancing the efficiency of POC testing.

Home Collection HbA1c Testing Kits

• The increasing use of home testing kits is providing patients with convenient and accessible options for monitoring their diabetes.

Advances in Testing Technologies

• Continuous advancements in testing technologies, such as capillary electrophoresis, are improving the accuracy and reliability of POC HbA1c tests.

Rising Diabetes Prevalence Fuels Market Growth

The increasing prevalence of diabetes significantly propels the growth of the POC HbA1c testing market. Factors such as long working hours, sedentary lifestyles, and poor dietary habits contribute to this rise. For instance, the International Diabetes Federation reported approximately 537 million adults with diabetes in 2021, expected to reach 643 million by 2030. The POC HbA1c assays enable convenient and rapid testing in community settings and healthcare facilities without the need for laboratories, making them crucial in managing this growing health issue.

Technological Advances Transforming Patient Diagnoses

Technological innovations are revolutionizing the POC HbA1c testing market. Companies are investing in advanced technologies to deliver fast and accurate results. For example, Abbott’s Afinion HbA1c Dx assay, an FDA-cleared rapid POC test, provides reliable results in just three minutes. This allows healthcare professionals to diagnose diabetes and evaluate patients efficiently, facilitating timely and individualized care plans.

Strategic Partnerships Enhancing Market Reach

Precision Diabetes and DxGen Corp. Partnership

• In August 2022, Precision Diabetes, Inc., and DxGen Corp. partnered to market the Epithod AutoDx, a fully automatic POC analyzer. This partnership aims to offer comprehensive diabetes tests in point-of-care settings, providing real-time actionable results and improving patient outcomes.

Market Segmentation

The POC HbA1c testing market is segmented by:

Type of Product

• Instruments
• Consumables

Technology

• Ion-Exchange HPLC
• Enzymatic Assay
• Affinity Binding Chromatography
• Immunoassay
• Other Technologies

End User

• Hospitals
• Physician Office/Outpatient Center
• Home Care
• Other End Users

North America was the largest region in the POC HbA1c testing market in 2023, while Africa is expected to be the fastest-growing region in the forecast period.

Conclusion

The POC HbA1c testing market is on a robust growth trajectory, driven by rising diabetes prevalence, technological advancements, and strategic industry partnerships. With increasing accessibility and the need for rapid testing solutions, the market is set to expand significantly, offering improved patient care and management in the coming years.

Request A Sample Of The Global Poc Hba1C Testing Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=6833&type=smp